The increase in blood levels of IL-6 observed was accompanied by elevated concentrations of CRP; therefore, determining the concentration of this cytokine was supposed to be a predictor of survival in patients with gastric cancer, and determining the concentration of CRP was to be a factor in the progression of cancer and stages of malignancy [7, 23]. This evidence concerns the gene IL6 and gastric cancer.